Popular Articles

Novavax And The NIH Agree To Evaluate A Virus-like Particle (VLP) Vaccine Candidate Against The Novel Influenza A (H1N1) Virus
Novavax, Inc. (Nasdaq: NVAX) and the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) have signed an agreement to cooperate in the evaluation of a virus-like particle (VLP) vaccine candidate against the novel influenza A (H1N1) virus. Novavax has produced influenza A (H1N1) VLP vaccine against the strain recommended by the Centers for Disease Control and Prevention (CDC).

Study Shows Consistent Use Of Insulin Pump Therapy, Augmented With Continuous Glucose Monitoring, Results In Significant A1C Reductions
Medtronic, Inc. (NYSE: MDT) announced results of a randomized, controlled trial to demonstrate the benefits of an insulin pump therapy augmented with real-time continuous glucose monitoring (Personal CGM) versus a conventional pump and self-monitoring of blood glucose in type 1 diabetes patients with poor metabolic control. Study findings showed that patients who used Personal CGM more than 70 percent of the time achieved nearly a full percentage point reduction in A1C (average blood glucose levels). The results were presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) in New Orleans.
News of the day
What Is The Difference Between Hip Resurfacing And Total Hip Replacement?
If hip resurfacing is an option, the surgeon will simply reshape the damaged surface of the femoral ball and then cover it with a round metal cap. The limitation here is that the procedure only works for bone that is not too damaged by arthritis. Generally speaking, surface replacements are not performed on patients with serious arthritic conditions, because if the bone is not strong enough, there is a small but real risk of fracturing. Therefore the average age of resurfacing patients may be 50 years or younger. Statistically, the resurfacing operation is an option for about 7 out of a 100 patients.
Medical Devices

Lancet Articles Address Variety Of Global Health Issues

Health Community Should Welcome Human Rights Community"s Help With Reducing Maternal Deaths Efforts by the human rights community to reach the 2015 U.N. Millennium Development Goal of reducing maternal deaths by three-quarters "should be welcomed by the health community," according to a Lancet editorial. "The health community must be willing to learn about human rights, realise the common ground, and work with human-rights professionals in a respectful, constructive, and practical partnership to prevent the unacceptably high number of maternal deaths that occur each year," writes the Lancet (Lancet, 6/27). Cash Transfers Can Improve Child Health "Accumulating evidence from large-scale programmes is starting to show positive effects of cash transfer programmes on many levels," and a new Save the Children report "highlights the importance of regular cash transfers, such as child benefits or pensions, as one crucial intervention to get Millennium Development Goal 4 - reduction of mortality in children younger than 5 years by two-thirds - back on track," a Lancet editorial writes. The report makes "a very strong case to include child and maternal cash transfers, especially for young children, into the package of interventions to reduce neonatal and child mortality," according to the journal (Lancet [2], 6/27). More Evidence Needed To Support AMFm In a Lancet Infectious Diseases reflection and reaction piece, Roger Bate of the American Enterprise Institute and Kimberly Hess of Africa Fighting Malaria examine the Affordable Medicines Facility for malaria (AMFm), which aims "to increase access to artemisinin-based combination therapies (ACTs) for the treatment of malaria" through subsidies. Although AMFm proponents cite "data from four pilot ACT subsidies as evidence that a worldwide ACT subsidy would be successful, "a report compiled by the Clinton Foundation and otherṣ€¦ offers no conclusive evidence that the AMFm will achieve its goals and would therefore caution against such enthusiasm," they write. "There are always costs of both action and inaction; however, before a costly scheme is funded, better evidence of its effectiveness should be established," according to Bate and Hess (Bate/Hess, Lancet Infectious Diseases, 7/09). Economic Crisis Presents Opportunity For Health System Strengthening The current economic crisis, while "placing additional strains on a world that is already overburdened by its inability to meet the basic needs of billions of its inhabitants," also presents the opportunity for health system strengthening, writes Julio Frenk, dean of the Harvard School of Public Health, in a comment appearing in the Lancet. Frenk writes, "There are several concrete actions to protect health during times of crisis, which the G8 could support as part of its efforts to strengthen health systems," such as enhanced information systems and a commitment to the protection of health workers and workforce programs despite tightening budgets. "A crisis is not the time to stagnate into the status quo, but to be bold and imaginative in introducing innovations for universal social protection," Frenk writes (Frenk, Lancet, 6/27). HIV-Positive Children And Pneumococcal Vaccination While efforts are underway in Rwanda to vaccinate all infants against pneumococcal disease by the end of 2009, an editorial appearing in Lancet Infectious Disease says "equally at risk older children with HIV are unfortunately not yet on the agenda." Streptococcus pneumoniae "claims the lives of up to 1 million children every year," with the deaths "disproportionately represented in the developing world, particularly in children infected with HIV of whom there are about 2 million in sub-Saharan Africa alone." The authors conclude, "Global vaccination of children against pneumococcal disease is important, but will take time; we argue that vaccinating children that are HIV-positive is more feasible and worth implementing now" (Meehan et al., Lancet Infectious Diseases, 7/09). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):